DePuy Synthes, the orthopedic and neurological branch ofJohnson & Johnson, has invested €36 million through its Ireland Innovation Centre to advance material science in 3D printing.
This investment will contribute to R&D at DePuy Synthes’ Materials and Surface Technology Centre,Johnson & Johnson’s 3D Printing Centre of Excellence, and theAdvanced Materials + BioEngineering Research(AMBER) centre.
Simon Coveney, the Irish Deputy Prime Minister and Minister for Foreign Affairs and Trade, announced this investment, which has also created 30 jobs at the company’s Ringaskiddy facility.科维尼说:
“DePuy Synthes’ investment of €36 million in innovation and the addition of 30 jobs at the company’s Materials Centre of Excellence is fantastic news for the region, and clearly demonstrates the strong commitment by DePuy to the site.”
The DePuy Synthes Innovation Centre
The DePuy Synthes Innovation Centre was established a decade ago to integrate new technologies for the company’s orthopedic portfolio, which includes3D打印的患者特异性植入物.
This new investment will specifically aid a five-year project focusing on advancing material science in 3D printing, coatings and surface treatments for higher quality implants and medical devices. In addition, a 3D Printing Development and Launch Center will be established.
“Ireland continues to evolve its global leadership position in the manufacture of high value, highly regulated innovative products and services,” stated Martin Shanahan, CEO ofIDA Ireland, a foreign direct investment agency, who also contributed to this investment.
“在这方面，真正站在世界舞台上的典范包括Depuy合成，他们被确定为一个World Economic Forum Lighthouse因为他们的流程驱动数字双胞胎计划在科克的“未来工厂”中率先开创。今天对该网站的进一步投资是对团队的人才，远见和能力的明确认可。”
DePuy Synthes and 3D bioprinting
Last year, DePuy Synthes andMaterialise, aBelgian software and 3D printing service provider,扩大了他们的伙伴关系to develop the TRUMATCH Personalized Solutions Shoulder System. This system enables surgeons to plan, design and order patient-specific 3D printed guides for shoulder operations.
Following this, DePuy Synthesstrengthened its interbody implant portfoliowhich includes titanium integrated PEEK technology for minimally invasive spinal surgeries. Gary Clerkin, Global Leader, Manufacturing Engineering, Science & Technology, DePuy Synthes, explained:
“It is crucial that we continue to deliver impactful research outcomes, and this advanced Materials and Surface Technology Centre will help accelerate innovation through the supply chain and shape the products of the future.”
Furthermore, theAMBER centrewill continue its research project to develop 3D bioprinted implants for people suffering from osteoarthritis within DePuy Synthes’ project. Clerkin added:
“这项投资的核心元素,3 d普林斯顿ting Development and Launch Centre, complements the 3D Bioprinting partnership with Trinity College Dublin launched last year.”
Nominations for 3D Printing Industry Awards 2019are still open. Let us know the enterprises, technology, and individuals who stood out in the additive manufacturing sector.
Want the latest medical and dental 3D printing news? Subscribe to the3D Printing Industry newsletter， 跟着我们Twitterand like us onFacebook.
Looking for a fresh start this year? Visit3D Printing Jobsto commence your career in additive manufacturing.
Featured image shows the DePuy Synthes facility in Lough Beg, Ringaskiddy, Ireland. Photo via Mark Redmond twitter/American Chamber of Commerce Ireland.
